All In Biotech

Free tool

FAERS Monitor: Prevymis

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209940 or its brand name (Prevymis, Letermovir). Reports on generic versions are filed under their own applications.

Reports

3,257

Serious

2,664

82% of reports

Hospitalization

1,280

Death reported

588

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use718
  • drug ineffective295
  • cytomegalovirus infection reactivation260
  • death196
  • acute kidney injury178
  • cytomegalovirus infection173
  • drug interaction166
  • product use in unapproved indication165
  • pancytopenia153
  • drug resistance99
  • hospitalisation99
  • pyrexia99
  • product dose omission issue98
  • cytomegalovirus viraemia96
  • diarrhoea93

Reports by year received

View as table
YearReports
20171
201882
2019257
2020272
2021395
2022379
2023413
2024503
2025557
2026398

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,902 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cytomegalovirus infection reactivationSignal260403.8357.997,958
cytomegalovirus viraemiaSignal96142.4116.713,054
cytomegalovirus infectionSignal17367.958.711,230
drug resistanceSignal9925.020.62,249
pancytopeniaSignal15317.715.22,398
acute kidney injurySignal1787.56.51,006
drug interactionSignal1666.85.8815
off label useSignal7185.35.02,606
product use in unapproved indicationSignal1654.33.7419
hospitalisationSignal994.23.4236
product dose omission issueSignal982.21.860
pyrexia991.81.538
death1961.51.330
drug ineffective2951.41.343
diarrhoea930.90.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.